<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Kazan medical journal</journal-id><journal-title-group><journal-title xml:lang="en">Kazan medical journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Казанский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0368-4814</issn><issn publication-format="electronic">2587-9359</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">104368</article-id><article-id pub-id-type="doi">10.17816/KMJ2022-815</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Social hygiene and healthcare management</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Социальная гигиена и организация здравоохранения</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Public awareness of evidence-based medicine, the Cochrane collaboration and drug selection ­approaches in pharmacies</article-title><trans-title-group xml:lang="ru"><trans-title>Осведомлённость населения о доказательной медицине, Кокрейновском сотрудничестве и подходы к выбору лекарств в аптеках</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5355-7828</contrib-id><name-alternatives><name xml:lang="en"><surname>Sharafutdinova</surname><given-names>Guzel N.</given-names></name><name xml:lang="ru"><surname>Шарафутдинова</surname><given-names>Гузель Наилевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>expert, Depart. of Clinical Pharmacology</p></bio><bio xml:lang="ru"><p>эксперт, отд. клинической фармакологии</p></bio><email>guzel_792@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8687-4857</contrib-id><name-alternatives><name xml:lang="en"><surname>Mullanurova</surname><given-names>Aliya F.</given-names></name><name xml:lang="ru"><surname>Мулланурова</surname><given-names>Алия Фаритовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>teacher</p></bio><bio xml:lang="ru"><p>преподаватель</p></bio><email>safina.aliya@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6322-4659</contrib-id><name-alternatives><name xml:lang="en"><surname>Korableva</surname><given-names>Anna A.</given-names></name><name xml:lang="ru"><surname>Кораблева</surname><given-names>Анна Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>M.D., Cand. Sci. (Med.), Clinical Pharmacologist</p></bio><bio xml:lang="ru"><p>канд. мед. наук, врач клинический фармаколог</p></bio><email>korablevaanna4@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3681-3447</contrib-id><name-alternatives><name xml:lang="en"><surname>Talipova</surname><given-names>Liliya I.</given-names></name><name xml:lang="ru"><surname>Талипова</surname><given-names>Лилия Илфаковна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>M.D., Clinical pharmacologist, Deputy General Director for Medical Affairs</p></bio><bio xml:lang="ru"><p>врач клинический фармаколог, зам. ген. директора по медицинской части</p></bio><email>tli13@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1999-0705</contrib-id><name-alternatives><name xml:lang="en"><surname>Ziganshina</surname><given-names>Liliya E.</given-names></name><name xml:lang="ru"><surname>Зиганшина</surname><given-names>Лилия Евгеньевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>M.D., D. Sci. (Med.), Prof., Leading Coordinator, Center for Translation of Evidence-Based Medical Knowledge; Kazan State Medical University; Chief Specialist in Clinical Pharmacology</p></bio><bio xml:lang="ru"><p>докт. мед. наук, проф., ведущий координатор, Центр трансляции доказательных медицинских знаний; Казанский ГМУ Минздрава России; главный специалист по клинической фармакологии</p></bio><email>lezign@gmail.com</email><xref ref-type="aff" rid="aff4"/><xref ref-type="aff" rid="aff5"/><xref ref-type="aff" rid="aff6"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2160-7720</contrib-id><name-alternatives><name xml:lang="en"><surname>Khairullin</surname><given-names>Rustem N.</given-names></name><name xml:lang="ru"><surname>Хайруллин</surname><given-names>Рустем Наилевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>M.D., D. Sci. (Med.), General Director</p></bio><bio xml:lang="ru"><p>докт. мед. наук, ген. директор</p></bio><email>icdc@icdc.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Interregional Clinical and Diagnostic Center</institution></aff><aff><institution xml:lang="ru">Межрегиональный клинико-диагностический центр</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">International School “Alabuga”</institution></aff><aff><institution xml:lang="ru">Международная школа «Алабуга»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">City Polyclinic No. 21</institution></aff><aff><institution xml:lang="ru">Городская поликлиника №21</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Russian Medical Academy of Continuous Professional Education</institution></aff><aff><institution xml:lang="ru">Российская медицинская академия непрерывного профессионального образования</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">Kazan State Medical University</institution></aff><aff><institution xml:lang="ru">Казанский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff6"><aff><institution xml:lang="en">Peoples' Friendship University of Russia</institution></aff><aff><institution xml:lang="ru">Российский университет дружбы народов</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-10-03" publication-format="electronic"><day>03</day><month>10</month><year>2022</year></pub-date><volume>103</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>815</fpage><lpage>823</lpage><history><date date-type="received" iso-8601-date="2022-03-02"><day>02</day><month>03</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-09-01"><day>01</day><month>09</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Эко-Вектор</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2025-10-03"/></permissions><self-uri xlink:href="https://kazanmedjournal.ru/kazanmedj/article/view/104368">https://kazanmedjournal.ru/kazanmedj/article/view/104368</self-uri><abstract xml:lang="en"><p><bold>Background.</bold> The importance of the appropriate use of medicines by the population (consumers of health services) based on the principles and achievements of evidence-based medicine is widely recognized. However, little attention is paid to this issue all over the world, and the knowledge of the population about evidence-based medicine and sources of reliable information in Russia is practically not studied.</p> <p><bold>Aim.</bold> To study public awareness of evidence-based medicine and the practice of choosing medicines.</p> <p><bold>Material and methods.</bold> A descriptive study among the inhabitants of Russia was carried out. Information was collected using a questionnaire that respondents filled out on their own. A total of 238 people (representing the general population) participated in the study, and the responses of 134 people (individuals working in health care, patients and caregivers) to questions about information were additionally used.</p> <p><bold>Results.</bold> The study showed that the majority of the population has no knowledge about evidence-based medicine (58%) and the Cochrane Collaboration (84%). Compared with the general population, a higher proportion of people working in health care were aware of both evidence-based medicine in general (41% vs. 26%; p=0.04) and the Cochrane Collaboration (37% vs. 5%; p=0.000002). 137/372 (37%) respondents experienced difficulties in choosing drugs in pharmacies, without significant differences between men and women. The most frequent difficulties in choosing medicines were ignorance of the comparative efficacy and safety of medicines, lack of understanding of the reasons for the variation in prices for the same medicine, the offer of predominantly expensive medicines by pharmacy workers, and the choice of the right medicine in a particular situation. When choosing medicines, the respondents most often relied on the recommendations of a doctor and a pharmacy worker. At the same time, half of the respondents also used other sources of information, the most popular of which was the Internet. The vast majority of respondents are interested in obtaining independent, evidence-based information about medicines.</p> <p><bold>Conclusion.</bold> A low level of public awareness of evidence-based medicine and difficulties in choosing medicines in a pharmacy were revealed.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Актуальность.</bold> Широко признана значимость надлежащего использования лекарственных средств населением (потребителями медицинских услуг) на основе принципов и достижений доказательной медицины. Однако этому вопросу уделяют мало внимания во всём мире, а знания населения о доказательной медицине и источниках достоверной информации в России практически не изучены.</p> <p><bold>Цель.</bold> Изучить осведомлённость населения о доказательной медицине и практику выбора лекарств.</p> <p><bold>Материал и методы исследования.</bold> Выполнено описательное исследование среди жителей России. Сбор сведений проводили с помощью анкеты, которую респонденты заполняли самостоятельно. Всего в исследовании приняли участие 238 человек (представляющих население в целом), и были дополнительно использованы ответы 134 человек — медицинских работников, пациентов и лиц, осуществляющих уход, по вопросам об информации.</p> <p><bold>Результаты.</bold> Исследование показало, что основная часть населения не имеет знаний о доказательной медицине (58%) и Кокрейновском сотрудничестве (84%). По сравнению с населением в целом бо́льшая доля людей, работающих в здравоохранении, была осведомлена как о доказательной медицине в целом (41% по сравнению с 26%; p=0,04), так и о Кокрейновском сотрудничестве (37% по сравнению с 5%; p=0,000002). Испытывали трудности при выборе лекарств в аптеках 137/372 (37%) респондентов без достоверных различий между мужчинами и женщинами. Наиболее частыми затруднениями при выборе лекарств были незнание сравнительной эффективности и безопасности лекарств, непонимание причин разброса цен на одно и то же лекарство, предложение преимущественно дорогих лекарств работниками аптеки, а также выбор подходящего лекарства в конкретной ситуации. При выборе лекарств респонденты наиболее часто ориентировались на рекомендации врача и работника аптеки. Вместе с тем, половина опрашиваемых также использовали другие источники информации, наиболее популярным среди которых был интернет. Подавляющее большинство респондентов заинтересованы в получении независимой, основанной на доказательствах информации о лекарствах.</p> <p><bold>Вывод.</bold> Выявлены низкий уровень осведомлённости населения о доказательной медицине и трудности при выборе лекарств в аптеке.</p></trans-abstract><kwd-group xml:lang="en"><kwd>adults</kwd><kwd>cross-sectional descriptive study</kwd><kwd>questionnaire</kwd><kwd>evidence-based medicine awareness</kwd><kwd>Cochrane</kwd><kwd>Cochrane Collaboration</kwd><kwd>drug choice in pharmacies</kwd><kwd>population</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>взрослые</kwd><kwd>поперечное описательное исследование</kwd><kwd>анкетирование</kwd><kwd>осведомлённость о доказательной медицине</kwd><kwd>Кокрейн</kwd><kwd>Кокрейновское сотрудничество</kwd><kwd>выбор лекарств в аптеках</kwd><kwd>население</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Greenhalgh T, Howick J, Maskrey N, Evidence Based Medicine Renaissance Group. Evidence based medicine: a movement in crisis? BMJ. 2014;348:g3725. DOI: 10.1136/bmj.g3725.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Carter E, Ryan-Vig S, Eisinga A. Cochrane at the WHO: Identifying and charting the impact of Cochrane evidence. Cochrane Community. https://community.cochrane.org/news/cochrane-who-identifying-and-charting-impact-cochrane-evidence (access date: 25.02.2022).</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>World Health Organization. The world medicines situation 2011 — Rational use of medicines (report No.: WHO/EMP/MIE/2011.2.2). 3rd Edition. Geneva: WHO; 2011. https://www.who.int/publications/i/item/WHO-EMP-MIE-2011-2.4 (access date: 25.02.2022).</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>World Health Organization. The pursuit of responsible use of medicines: Sharing and learning from country experiences (report No.: WHO/EMP/MAR/2012.3). Geneva: WHO; 2012. https://www.who.int/publications/i/item/WHO-EMP-MAR-2012.3 (access date: 25.02.2022).</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>World Health Organization. WHO medicines strategy: Framework for action in essential drugs and medicines policy — 2000–2003 (report No.: WHO/EDM/2000.1). Geneva: WHO, 2000. http://apps.who.int/medicinedocs/en/d/Jwhozip16e (access date: 25.02.2022).</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Cochrane consumers Network. About Cochrane and its consumers. https://consumers.cochrane.org/healthcare-users-cochrane (access date: 25.02.2022).</mixed-citation></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Kokreyn Rossiya. Nashe videnie, missiya, printsipy. (Cochrane Russia. Our vision, mission, principles.) https://russia.cochrane.org/ru (access date: 25.02.2022). (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Кокрейн Россия. Наше видение, миссия, принципы. https://russia.cochrane.org/ru (дата обращения: 25.02.2022).</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><mixed-citation>Abdo-Rabbo A, Al-Ansari M, Gunn BC, Suleiman BJ. The use of medicines in oman: Public knowledge, attitudes and practices. Sultan Qaboos Univ Med J. 2009;9(2):124–131. PMID: 21509288.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Ziganshina LE, Yudina EV, Talipova LI, Sharafutdinova GN, Khairullin RN. Smart and age-friendly cities in Russia: An exploratory study of attitudes, perceptions, quality of life and health information needs. Int J Environ Res Public Health. 2020;17(24):9212. DOI: 10.3390/ijerph17249212.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Sackett D, Rosenberg W, Gray M, Haynes B, Richardson S. Evidence based medicine: What it is and what it isn’t. BMJ. 1996;312:71–72. DOI: 10.1136/bmj.312.7023.71.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Fisher R. On the interpretation of χ2 from contingency tables, and the calculation of P. J R Stat Soc. 1922;85:87. DOI: 10.2307/2340521.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Cochrane. About us. https://www.cochrane.org/about-us (access date: 25.02.2022).</mixed-citation></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Synonym dictionary. https://synonymonline.ru (access date: 25.02.2022). (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Словарь синонимов. synonymonline.ru (дата обращения: 25.02.2022).</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><mixed-citation>Gellad ZF, Lyles KW. Direct-to-consumer advertising of pharmaceuticals. Am J Med. 2007;120(6):475–480. DOI: 10.1016/j.amjmed.2006.09.030.</mixed-citation></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Vasilenko OV. Hazardous consumer behavior on buying medicinal products (as exemplified by Volgograd). The review of economy, the law and sociology. 2011;(2):185–187. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Василенко О.В. Рисковое потребительское отношение при покупке лекарственных средств (на примере Волгограда). Вестник экономики, права и социологии. 2011;(2):185–187.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><mixed-citation>Andreassen HK, Bujnowska-Fedak MM, Chronaki CE, Dumitru RC, Pudule I, Santana S, Voss H, Wynn R. European citizens' use of E-health services: a study of seven countries. BMC Public Health. 2007;7:53. DOI: 10.1186/1471-2458-7-53.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Hesse BW, Nelson DE, Kreps GL, Robert TС, Neeraj KA, Barbara KR, Kasisomayajula V. Trust and sources of health information: The impact of the Internet and its implications for health care providers. Findings from the First Health Information National Trends Survey. Arch Intern Med. 2005;165(22):2618–2624. DOI: 10.1001/archinte.165.22.2618.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Fox S, Duggan M. Part two: Sources of health information. Pew Research Center (Washington). http://www.pewinternet.org/2013/11/26/part-two-sources-of-health-information (access date: 25.02.2022).</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Nejašmić D, Miošić I, Vrdoljak D, Permozer HS, Tomičić M, Gmajnić R, Diminić LI, Sironić Hreljanović J, Pleh V, Cerovečki V, Tomljenović A, Bekić S, Jerčić M, Tuđa K, Puljak L. Awareness and use of evidence-based medicine information among patients in Croatia: A nation-wide cross-sectional study. Croat Med J. 2017;58(4):300–309. DOI: 10.3325/cmj.2017.58.300.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Dawood OT, Hassali MA, Saleem F. Factors affecting knowledge and practice of medicine use among the general public in the State of Penang, Malaysia. J Pharm Health Serv Res. 2017;8:51–57. DOI: 10.1111/jphs.12167.</mixed-citation></ref></ref-list></back></article>
